5Simor AE,Lee M,Vearncombe M,et al. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol, 2002,23 : 261-267.
6Harris A,Torrres Viera C, Venkartaraman L, et al. Epidemiology and clinical outcomes of patients with multiresistant pseudomonas aeruginosa. Clin Infect Dis, 1999, 28:1 128-1 133.
7Garcia Rodriguez J A, Jones R N. Antimicrobial resistance in gramnegative isolates from European intensive care units : data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme . J Chemother,2002,14(1) :25-32.
8Paton R, Miles RS, Amyes, et al. Biochemical properties of inducible β-1actamases produced from Xanthomonas maltophilia. Antimicrob Agents Chemother, 1994,38:2 143-2 149.
